Strokes are a leading cause of death and disability worldwide, leaving a pressing need for effective neuroprotective drugs. 

A team of researchers from the University of Copenhagen led by Prof Petrine Wellendorph have developed a promising drug candidate that may offer a chance for improving brain function and working memory among stroke patients. 

Their work is funded by the Novo Nordisk foundation, and details can be seen on the Wellendorph Lab webpage here: https://drug.ku.dk/disciplines/molecular-and-cellular-pharmacology/wellendorph-lab/

Read their original article here: https://journals.sagepub.com/doi/10.1177/0271678X231167920